NanoEntek Obtains German Approval for COVID-19 Antigen Test Kit

[Asia Economy Reporter Jang Hyowon] NanoEntek (CEO Jeong Chan-il) announced on the 2nd that its COVID-19 antigen diagnostic kit (FREND COVID19 Ag), which detects antigens of the novel coronavirus (COVID-19), has received usage approval from the German Federal Ministry of Health.

The COVID-19 antigen diagnostic kit directly tests for antigens entering the infected person's body through droplets, enabling diagnosis even in early-stage patients, unlike antibody tests. Additionally, it does not require expensive equipment like molecular diagnostics, making it affordable and easy to use, which has led to rapidly increasing global demand.

Germany, along with other European countries, has recently been experiencing a rapid resurgence of COVID-19 cases. The German government has announced strong restrictive measures for one month starting November 2nd, reflecting the severity of the situation. Restaurants are limited to takeout only, sports events and performances are canceled, unnecessary travel is discouraged, and hotel stays are restricted.

In such a pandemic, managing a vast amount of patient results is very important. NanoEntek's FREND System is equipped with Laboratory Information System (LIS) functionality, allowing automatic transmission of results and effective management of patient information without omissions. Therefore, it enables accurate and easy patient monitoring and can be usefully applied to establish a government-level Infectious Disease Surveillance system.

A NanoEntek official stated, “Sales of COVID-19 diagnostic kits are steadily increasing,” and added, “Starting from the fourth quarter, exports to new countries including the United States will begin, so we expect stable sales growth.”

This content was produced with the assistance of AI translation services.